[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Fazeelat Bibi\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":40},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":5},"100600387","efficacy-of-tetrachlorodecaoxide-tcdo-drops-in-chronic-wound-healing-100600387",false,"NCT07096830","Efficacy of Tetrachlorodecaoxide (TCDO) Drops in Chronic Wound Healing","Efficacy of Tetrachlorodecaoxide (TCDO) Drops in Chronic Wound Healing: Insights From a Randomized Controlled Trial","TCDO-Wound","Inclusion Criteria:\n\n* Adults \\> 18 years diagnosed with chronic wounds (duration \\> 6 weeks)\n* Wound size between 5 and 10 cm²\n* Adequate perfusion:\n* Ankle-Brachial Pressure Index (ABPI) \\> 0.8 for venous leg ulcers\n* Palpable pulses for diabetic foot ulcers\n\nExclusion Criteria:\n\n* Patients receiving immunosuppressive therapy or corticosteroids\n* Presence of malignancy\n* Patients who do not provide informed consent","ALL","18 Years",{"count":20,"type":21},66,"ESTIMATED","INTERVENTIONAL",[24],"NA","This is a single-center, randomized controlled trial evaluating the effectiveness of topical tetrachlorodecaoxide (TCDO) solution in enhancing chronic wound healing. The study will compare standard wound care with and without the addition of topical TCDO drops. Eligible adult participants with chronic wounds of more than six weeks' duration will be randomly assigned to either the intervention or control group. The trial aims to assess the rate of wound healing, time to 50% wound closure, pain reduction measured by the Visual Analog Scale (VAS), and cost-effectiveness.",[27],"Chronic Wound Care","NOT_YET_RECRUITING","2025-07-31",{"date":31,"type":32},"2025-08-05","ACTUAL",{"date":34,"type":21},"2025-08-30",{"date":36,"type":21},"2026-08-30",{"name":38,"class":39},"Fazeelat Bibi","OTHER",""]